TREATMENT
Review: central venous catheters treated with anti-infective agents prevent catheter-related bloodstream infections
| The first 150 words of the full text of this article appear below. |
Do central venous catheters treated with anti-infective agents (AI-CVCs) prevent catheter-related bloodstream infections (CRBSIs)?
Included studies compared AI-CVCs with standard CVCs or a different AI-CVC for preventing CRBSIs in patients requiring a CVC. Primary outcome was diagnosis of a CRBSI (the same micro-organism identified in both the catheter and the bloodstream).
Medline, EMBASE/Excerpta Medica, SCI/Web of Science, SCI/ISI Proceedings, and Cochrane Library (to Sep 2007) were searched for randomised controlled trials (RCTs). Trials involving AI-CVCs that required in-house preparation were excluded. 38 RCTs (n =
9000 patients) met the selection criteria. Methodological quality of the trials was generally poor: 10 RCTs reported adequate concealment of allocation, and 19 RCTs reported blinding of patients, healthcare providers, or outcome assessors. 27 trials that reported appropriate measures of CRBSI were included in the meta-analysis. 6 trials compared 2 different AI-CVCs, but results were not reported in this paper.*
AI-CVCs reduced risk of CRBSI
Academic Medical Centre, University of Amsterdam Amsterdam, The Netherlands
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
